Your browser doesn't support javascript.
loading
Chimeric Antigen Receptor-Glypican-3 T-Cell Therapy for Advanced Hepatocellular Carcinoma: Results of Phase I Trials.
Shi, Donghua; Shi, Yaoping; Kaseb, Ahmed O; Qi, Xingxing; Zhang, Yuan; Chi, Jiachang; Lu, Qing; Gao, Huiping; Jiang, Hua; Wang, Huamao; Yuan, Daijing; Ma, Hong; Wang, Hongyang; Li, Zonghai; Zhai, Bo.
Afiliación
  • Shi D; Department of Interventional Oncology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Shi Y; Department of Interventional Oncology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Kaseb AO; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Qi X; Department of Interventional Oncology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Zhang Y; Department of Interventional Oncology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Chi J; Department of Interventional Oncology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Lu Q; Department of Radiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Gao H; CARsgen Therapeutics Ltd., Shanghai, China.
  • Jiang H; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Wang H; CARsgen Therapeutics Ltd., Shanghai, China.
  • Yuan D; CARsgen Therapeutics Ltd., Shanghai, China.
  • Ma H; CARsgen Therapeutics Corp., Houston, Texas.
  • Wang H; International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgical Hospital, Second Military Medical University, Shanghai, China.
  • Li Z; CARsgen Therapeutics Ltd., Shanghai, China. zhaiboshi@sina.com zonghaili@163.com.
  • Zhai B; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Clin Cancer Res ; 26(15): 3979-3989, 2020 08 01.
Article en En | MEDLINE | ID: mdl-32371538
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Inmunoterapia Adoptiva / Carcinoma Hepatocelular / Fiebre / Síndrome de Liberación de Citoquinas / Neoplasias Hepáticas / Recurrencia Local de Neoplasia Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Inmunoterapia Adoptiva / Carcinoma Hepatocelular / Fiebre / Síndrome de Liberación de Citoquinas / Neoplasias Hepáticas / Recurrencia Local de Neoplasia Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: China